Art

J-GLOBAL ID：201802254364836510   Reference number：18A0532775

Amelioration of NK cell function driven by Vα24⁺ invariant NKT cell activation in multiple myeloma

多発性骨髄腫におけるVα24~+インバリアントNKT細胞活性化により駆動されるNK細胞機能の改善【Powered by NICT】

Author (9)： Iyoda Tomonori (Laboratory for Immunotherapy, RIKEN Center for Integrative Medical Science (IMS), Yokohama, Japan) ,  Yamasaki Satoru (Laboratory for Immunotherapy, RIKEN Center for Integrative Medical Science (IMS), Yokohama, Japan) ,  Hidaka Michihiro (National Hospital Organization Kumamonoto Medical Center, Clinical laboratory, Japan) ,  Kawano Fumio (National Hospital Organization Kumamonoto Medical Center, Clinical laboratory, Japan) ,  Abe Yu (Japanese Red Cross Medical Center, Department of hematology, Japan) ,  Suzuki Kenshi (Japanese Red Cross Medical Center, Department of hematology, Japan) ,  Kadowaki Norimitsu (Kagawa University, Department of Internal Medicine, Japan) ,  Shimizu Kanako (Laboratory for Immunotherapy, RIKEN Center for Integrative Medical Science (IMS), Yokohama, Japan) ,  Fujii Shin-ichiro (Laboratory for Immunotherapy, RIKEN Center for Integrative Medical Science (IMS), Yokohama, Japan)
Material： Clinical Immunology  (Clin Immunol)
Volume： 187  Page： 76-84  Publication year： 2018 
JST Material Number： A1154A  ISSN： 1521-6616  Document type： Article
Article type： 原著論文  Country of issue： Netherlands (NLD)  Language： ENGLISH (EN)

Abstract/Point： NK cells represent a first lin...

Register(free) or Log In to access     To see more with JDream III (charged).   {{ this.onShowAbsJLink("http://jdream3.com/lp/jglobal/index.html?docNo=18A0532775&from=J-GLOBAL&jstjournalNo=A1154A") }}

Thesaurus term： *NK cell ,  immunosuppression ,  complex (compound) ,  antitumor action ,  therapy ,  population (ecology) ,  patient ,  *Multiple Myeloma ,  natural immunity ,  myeloma cell ,  *NKT Cell ,  Antigens, CD1d ,  peripheral blood mononuclear cell ,  immune protection ,  *iNKT cell ,  reaction ,  immune response ,  suppression and control

Author keywords (4)： NK cells ,  NKT cells ,  Multiple myeloma ,  Innate immunity

JST classification (2)： Infectious immunity  (ED03030P) ,  Immunotherapy for tumors  (GE03035B)

Terms in the title (4)： 多発性骨髄腫 ,  インバリアントNKT細胞 ,  活性化 ,  NK細胞